血红蛋白水平对COVID-19呼吸衰竭患者心脏骤停或卒中复合结局的影响
该研究为对前瞻性收集数据库的回顾性分析,纳入超过370个国际中心ICU中年龄大于18岁的急性COVID-19感染患者,评估入ICU时血红蛋白水平与入ICU后30天内心脏骤停或卒中复合结局的关系。6926例患者中760例(11.0%)发生卒中(2.0%)和/或心脏骤停(9.4%);正常血红蛋白者复合结局发生率为12.8%,轻度贫血为13.3%,中/重度贫血为16.7%。以死亡为竞争风险行Cox比例风险回归,中/重度贫血与心脏骤停或卒中风险升高相关(HR 1.32;95%CI 1.05-1.67)。
要点
- 6926例ICU的COVID-19患者中,760例(11.0%)发生卒中(2.0%)和/或心脏骤停(9.4%)。
- 复合结局发生率:正常血红蛋白12.8%,轻度贫血13.3%,中/重度贫血16.7%。
- 以死亡为竞争风险校正后,中/重度贫血与心脏骤停或卒中风险升高相关(HR 1.32;95%CI 1.05-1.67)。
- 贫血定义:女性正常≥12.0 g/dL、男性≥13.5 g/dL;轻度女性10.0-11.9 g/dL、男性10.0-13.4 g/dL;中/重度<10.0 g/dL。
适用人群与场景
- 年龄大于18岁的急性COVID-19感染并收入ICU的患者,来自超过370个国际中心的重症监护登记数据库。
诊断标准与关键阈值
- 贫血分级:正常为女性血红蛋白≥12.0 g/dL、男性≥13.5 g/dL;轻度为女性10.0-11.9 g/dL、男性10.0-13.4 g/dL;中度为女性及男性血红蛋白≥8.0且<10.0 g/dL;重度为女性及男性血红蛋白<8.0 g/dL。
研究设计与关键结果
- 研究类型:对前瞻性收集数据库的回顾性分析,纳入6926例患者(中位年龄59岁,男性65%)。
- 主要复合结局:760例(11.0%)发生卒中(2.0%)和/或心脏骤停(9.4%)。
- 按贫血状态分组复合结局发生率:正常血红蛋白12.8%,轻度贫血13.3%,中/重度贫血16.7%。
- 以死亡为竞争风险的Cox比例风险回归(协变量:年龄、性别、合并症(糖尿病、高血压、肥胖、心脏或神经系统疾病)、大流行时期、国家收入、机械通气、体外膜氧合)显示,中/重度贫血与心脏骤停或卒中风险升高相关(HR 1.32;95%CI 1.05-1.67)。
证据类型、等级与局限
- 证据类型:对前瞻性收集数据库的回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在ICU的COVID-19患者中,中/重度贫血与心脏骤停或卒中风险升高相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Anemia has been associated with an increased risk of both cardiac arrest and stroke, frequent complications of COVID-19. The effect of hemoglobin level at ICU admission on a composite outcome of cardiac arrest or stroke in an international cohort of COVID-19 patients was investigated.
DESIGN: Retrospective analysis of prospectively collected database.
SETTING: A registry of COVID-19 patients admitted to ICUs at over 370 international sites was reviewed for patients diagnosed with cardiac arrest or stroke up to 30 days after ICU admission. Anemia was defined as: normal (hemoglobin ≥ 12.0 g/dL for women, ≥ 13.5 g/dL for men), mild (hemoglobin 10.0-11.9 g/dL for women, 10.0-13.4 g/dL for men), moderate (hemoglobin ≥ 8.0 and < 10.0 g/dL for women and men), and severe (hemoglobin < 8.0 g/dL for women and men).
PATIENTS: Patients older than 18 years with acute COVID-19 infection in the ICU.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Of 6926 patients (median age = 59 yr, male = 65%), 760 patients (11.0%) experienced stroke (2.0%) and/or cardiac arrest (9.4%). Cardiac arrest or stroke was more common in patients with low hemoglobin, occurring in 12.8% of patients with normal hemoglobin, 13.3% of patients with mild anemia, and 16.7% of patients with moderate/severe anemia. Time to stroke or cardiac arrest by anemia status was analyzed using Cox proportional hazards regression with death as a competing risk. Covariates selected through clinical knowledge were age, sex, comorbidities (diabetes, hypertension, obesity, and cardiac or neurologic conditions), pandemic era, country income, mechanical ventilation, and extracorporeal membrane oxygenation. Moderate/severe anemia was associated with a higher risk of cardiac arrest or stroke (hazard ratio, 1.32; 95% CI, 1.05-1.67).
CONCLUSIONS: In an international registry of ICU patients with COVID-19, moderate/severe anemia was associated with increased hazard of cardiac arrest or stroke.
参考来源
- Feng SN, Kelly TL, Fraser JF, et al. Impact of Hemoglobin Levels on Composite Cardiac Arrest or Stroke Outcome in Patients With Respiratory Failure Due to COVID-19. Crit Care Explor. 2024. PMID: 39172625. doi:10.1097/CCE.0000000000001143
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。